FDA approves ProHeart 12July 8, 2019The U.S. Food and Drug Administration’s (FDA’s) Center for Veterinary Medicine (CVM) has approved ProHeart 12 (moxidectin) extended release injectable suspension for dogs one year and older.
SPONSORED CONTENTFind success with your parvovirus protocolDiscover our Canine Parvovirus Monoclonal Antibody: puppies treated with CPMA experienced a 93% real-world survival rate, and were able to head home from the clinic almost two days earlier.1,2 + Read More
